CRA Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,616
Closed -$207K 300
2025
Q3
$207K Sell
1,616
-261
-14% -$31.8K 0.03% 285
2025
Q2
$227K Hold
1,877
0.03% 253
2025
Q1
$209K Buy
+1,877
New +$200K 0.04% 265
2024
Q4
Sell
-1,866
Closed -$215K 279
2024
Q3
$215K Buy
+1,866
New +$212K 0.04% 252
2021
Q3
Sell
-2,371
Closed -$216K 205
2021
Q2
$216K Sell
2,371
-25
-1% -$2.23K 0.08% 174
2021
Q1
$205K Hold
2,396
0.08% 165
2020
Q4
$226K Hold
2,396
0.1% 143
2020
Q3
$208K Hold
2,396
0.1% 135
2020
Q2
$209K Buy
+2,396
New +$207K 0.11% 128

Other funds holding NVS

CRA Financial Services's NVS Position: Q4 2025 in Review

CRA Financial Services sold out of Novartis (NVS) in Q4 2025, closing a stake of 1,616 shares — an estimated $207K sold.

CRA Financial Services first reported a position in NVS in Q2 2020 and held it in 9 quarters. The position peaked at $227K in Q2 2025. 1,508 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

  • CRA Financial Services reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
  • CRA Financial Services sold 1,616 Novartis shares in Q4 2025, an estimated $207K.
  • CRA Financial Services first reported a position in Novartis in Q2 2020 and held it in 9 quarters.
  • CRA Financial Services's Novartis position peaked at $227K in Q2 2025.
  • 1,508 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on CRA Financial Services's 13F filing for Q4 2025, filed 16 Jan 2026.